Select a Region
North America

Press Releases | EVERSANA - Part 4

EVERSANA
Posted on June 29, 20216/29/21

Evoke Pharma, EVERSANA and The International Foundation for Gastrointestinal Disorders Announce Membership into IFFGD’s Industry Council

EVERSANA
Posted on June 21, 20216/21/21

EVERSANA™ expands medical information and integrated compliance services across Europe

Posted on June 14, 20216/14/21

GENinCode announces major US commercialisation partnership with EVERSANA

Posted on June 3, 20216/3/21

Resverlogix and EVERSANA Announce Partnership to Support the Pending Launch of the Initial Commercialization of Apabetalone for COVID-19 in the United States and Canada

Posted on May 26, 20215/26/21

EVERSANA™ and S3 Connected Health Announce Strategic Partnership to Advance the Adoption and Commercialization of Digital Health Solutions Across Life Sciences

Posted on May 19, 20215/19/21

MedRhythms and EVERSANA announce partnership to launch and commercialize chronic stroke software-based medical device

EVERSANA
Posted on May 18, 20215/18/21

EVERSANA™ expands global agency and marketing capabilities through partnership with thenetworkone

EVERSANA
Posted on May 14, 20215/14/21

EVERSANA™ Leaders Jim Lang, Brigham Hyde Named to 2021 PM360 Elite 100 List

Posted on May 6, 20215/6/21

EVERSANA advances commercialization readiness as Humanigen announces publication of phase 3 randomized double-blind placebo-controlled study demonstrating the efficacy and safety of lenzilumab™ in newly hospitalized COVID-19 patients

EVERSANA
Posted on May 6, 20215/6/21

EVERSANA™ strengthens global market access and pricing leadership in European expansion